Quest Diagnostics (DGX) Financials

$241.49

$-0.41 (-0.17%)

As on 26-Oct-2026 15:43EDT

Market cap

$26,698 Mln

Revenue (TTM)

$11,841 Mln

P/E Ratio

25.7

P/B Ratio

3.4

Div. Yield

1.4 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	11,841.00	11,035.00	9,872.00	9,252.00	9,883.00	10,788.00
Cost of Revenue	7,916.00	7,512.00	6,628.00	6,199.00	6,450.00	6,579.00
Gross Profit	3,925.00	3,523.00	3,244.00	3,053.00	3,433.00	4,209.00
Operating Expenses	2,197.00	1,920.00	1,898.00	1,642.00	2,005.00	1,828.00
Operating Profit (EBIT)	1,728.00	1,603.00	1,346.00	1,262.00	1,428.00	2,381.00
Other Income	--	--	--	--	-11.00	447.00
Profit before Tax	1,499.00	1,360.00	1,194.00	1,130.00	1,279.00	2,677.00
Provision for Tax	342.00	314.00	273.00	-248.00	264.00	597.00
Profit after Tax (Net Income)	1,129.00	992.00	871.00	854.00	946.00	1,995.00
Minority Interest	-37.00	-54.00	-50.00	-56.00	-69.00	-85.00
Consolidated Profit	245.00	988.00	866.00	850.00	942.00	1,988.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	7,632.00	7,170.00	6,778.00	6,307.00	5,893.00	6,444.00
Minority Interest	-37.00	116.00	118.00	111.00	37.00	39.00
Non-Current Liabilities	7,356.00	6,661.00	7,088.00	5,789.00	5,279.00	5,296.00
Current Liabilities	1,834.00	2,278.00	2,169.00	1,815.00	1,551.00	1,753.00
Total Liabilities	19,055.00	16,225.00	16,153.00	14,022.00	12,837.00	13,611.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	14,104.00	13,847.00	13,761.00	11,650.00	10,939.00	10,870.00
Current Assets	3,117.00	2,378.00	2,392.00	2,372.00	1,898.00	2,741.00
Total Assets	20,338.00	16,225.00	16,153.00	14,022.00	12,837.00	13,611.00
Total Debt*	6,285.00	6,919.00	7,087.00	5,498.00	4,714.00	4,773.00
Net Current Assets	--	100.00	223.00	557.00	347.00	988.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	1,886.00	1,334.00	1,272.00	1,718.00	2,233.00
Cash Flow from Investing Activities	--	-631.00	-2,548.00	-1,061.00	-543.00	21.00
Cash from Financing Activities	--	-1,388.00	1,084.00	160.00	-1,732.00	-2,540.00
Net Cash Inflow / Outflow	--	--	--	--	-557.00	-286.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	10.08	8.86	7.71	7.56	8.23	15.96
Cash EPS ($)	--	13.95	12.07	11.50	12.03	19.22
Adjusted Book Value ($)	--	64.02	59.98	55.81	51.24	51.55
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	16.84	11.81	11.26	14.94	17.86
Free Cash Flow per Share ($)	--	12.13	8.04	7.65	11.43	14.64

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	7.10	6.79	7.62	8.67	17.51
ROE (%)	14.56	14.22	13.31	14.00	15.34	30.22
ROA (%)	5.84	6.13	5.77	6.36	7.15	14.44
EBIT Margin (%)	14.51	14.72	14.19	13.64	13.99	25.50
Net Margin (%)	9.53	8.99	8.82	9.23	9.58	17.76
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	9.13	0.12	0.07	-0.06	-0.08	0.14
EBIT Growth (%)	8.87	15.92	11.01	-8.75	-49.73	34.20
Net Profit Growth (%)	19.74	13.89	1.99	-9.73	-52.58	39.41
EPS Growth (%)	17.55	0.15	0.02	-0.08	-0.48	0.53
Book Value Growth (%)	6.09	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	25.68	19.59	19.57	18.24	19.02	10.84
Price / Book Value	3.45	2.71	2.52	2.47	3.05	3.36
Dividend Yield (%)	1.36	--	--	--	--	--
EV/EBITDA	14.06	11.82	12.45	16.16	12.30	8.07
Close Price ($)	233.07	173.53	150.86	137.88	156.44	173.01
High Price ($)	248.84	197.53	165.32	157.36	174.16	174.16
Low Price ($)	171.18	148.70	123.04	119.59	120.40	113.36
Market Cap ($ Cr)	26,698.21	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	--	0.96	1.05	0.87	0.80	0.74
Short term debt to equity ratio	0.03	0.09	0.14	0.09	0.04	0.04
Current Ratio	1.70	1.04	1.10	1.31	1.22	1.56
Quick Ratio	1.58	0.96	1.02	1.20	1.10	1.44
Interest Coverage	6.90	5.86	6.20	8.30	9.34	18.10

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	14.46	12.76	13.21	13.08	12.09	13.33
Asset Turnover	0.61	0.68	0.65	0.69	0.75	0.78
Receivable days	--	44.88	46.51	47.47	48.65	50.07
Inventory Days	--	9.17	10.42	11.25	11.33	11.96
Payable days	--	45.88	18.32	20.68	19.28	22.29
Cash Conversion Cycle	--	8.17	38.60	38.04	40.70	39.75

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)